The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo
Open Access
- 1 January 2005
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 65 (1), 73-82
- https://doi.org/10.1016/j.cardiores.2004.08.018
Abstract
Objective: The endogenous peptide apelin is differentially regulated in cardiovascular disease but the nature of its role in cardiac function remainsKeywords
This publication has 30 references indexed in Scilit:
- Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in VivoJournal of Biological Chemistry, 2004
- Altered Calcium Handling Is Critically Involved in the Cardiotoxic Effects of Chronic β-Adrenergic StimulationCirculation, 2004
- Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardiumThe Journal of Physiology, 2003
- Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac DysfunctionCirculation, 2003
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in manBritish Journal of Pharmacology, 2001
- Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing β2-adrenergic receptors in the heartCardiovascular Research, 2000
- Molecular and Functional Characteristics of APJJournal of Biological Chemistry, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- Modulation of Inotropic Therapy by Venodilation in Acute Heart FailureJournal of Cardiovascular Pharmacology, 1992